Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis.
Translational cancer research（2023）
摘要
In any line of treatment for HER2-positive metastatic breast cancer, the Pyrotinib-containing regimens demonstrated considerable tumor response, disease control, and survival with manageable adverse effects.
更多查看译文
关键词
HER2-positive,Pyrotinib,metastatic breast cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要